Amgen (NASDAQ:AMGN) shares snapped six straight sessions of gains, as the stock was down 3% at $306.2 on Wednesday. The ...
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback